<DOC>
	<DOC>NCT02800733</DOC>
	<brief_summary>anxiety disorder is one of the major public health problems worldwide. 25% of people experience anxiety disorders throughout life. Generalized anxiety disorder (GAD) is known as the most prevalent anxiety disorder. Saffron has previously approved as an effective adjuvant therapy in depression and might alleviate GAD symptoms.Since up to the best of our knowledge no human studies have assessed the therapeutic effect of saffron as an adjuvant therapy in GAD patients, Therefore, this study is planned to evaluateThe effect of saffron (Crocus satious L.) in the treatment of mild to moderate generalized anxiety disorder:</brief_summary>
	<brief_title>Effects of Saffron on Mild to Moderate Generalized Anxiety Disorder (GAD)</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Patients who diagnosed with GAD according to DSMV criteria, Hamilton score of 1825 pregnancy and lactation receiving antipsychotic medications in a month prior to the recruitment suffered from other psychological disorders (e.g. bipolar disorder, schizophrenia, mood disorders), and drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>